Mirae Asset Healthcare Fund holds 32 instruments (99.98% equity), led by Sun Pharmaceutical Industries Limited (10.15%), Divi's Laboratories Limited (9.79%) and Torrent Pharmaceuticals Limited (6.8%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of Mirae Asset Healthcare Fund, managed by Mirae Asset Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 32 instruments with an equity allocation of 99.98%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
Mirae Asset Healthcare Fund's top 10 holdings account for 58.42% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 98.08% of net assets, spread across 2 sectors in total. Since its 31 August 2026 disclosure, the fund added 0 new positions and exited 0 positions, with Narayana Hrudayalaya Ltd. seeing the largest move (-0.91pp to 0%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Dr. Reddy's Laboratories Limited | 3.94% → 4.84% | ▲ +0.9 |
| Neogen Chemicals Limited | 0.64% → 1.5% | ▲ +0.86 |
| SYMBIOTEC PHARMALAB LTD | 0.98% → 1.6% | ▲ +0.62 |
| Alkem Laboratories Limited | 3.39% → 3.76% | ▲ +0.37 |
| MOLBIO DIAGNOSTICS LTD | 1.44% → 1.77% | ▲ +0.33 |
| Aster DM Healthcare Limited | 3.01% → 3.32% | ▲ +0.31 |
| Laurus Labs Limited | 5.24% → 5.51% | ▲ +0.27 |
| Gland Pharma Limited | 2.44% → 2.69% | ▲ +0.25 |
| Krishna Institute of Medical Sciences Limited | 3.16% → 3.39% | ▲ +0.23 |
| Dr. Lal Path Labs Ltd. | 2.77% → 2.9% | ▲ +0.13 |
| Stock | Weight | Change |
|---|---|---|
| Narayana Hrudayalaya Ltd. | 0.91% → 0% | ▼ -0.91 |
| Sun Pharmaceutical Industries Limited | 10.9% → 10.15% | ▼ -0.75 |
| Fortis Healthcare Limited | 3.4% → 2.94% | ▼ -0.46 |
| Apollo Hospitals Enterprise Limited | 5.91% → 5.62% | ▼ -0.29 |
| Torrent Pharmaceuticals Limited | 7.06% → 6.8% | ▼ -0.26 |
| Max Healthcare Institute Limited | 2.58% → 2.35% | ▼ -0.23 |
| Glenmark Pharmaceuticals Limited | 4.99% → 4.78% | ▼ -0.21 |
| Anthem Biosciences Limited | 1.13% → 0.93% | ▼ -0.2 |
| Eris Lifesciences Limited | 2.55% → 2.39% | ▼ -0.16 |
| Lupin Limited | 2.4% → 2.27% | ▼ -0.13 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Mirae Asset Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.